Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective-Reference-Cited by-同舟云学术

Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective

Published:2021-06-02 Issue:3 Volume:53 Page:285-320
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Jala Aishwarya¹^ORCID,Ponneganti Srikanth¹^ORCID,Vishnubhatla Devi Swetha¹,Bhuvanam Gayathri¹,Mekala Prithvi Raju¹,Varghese Bincy²^ORCID,Radhakrishnanand Pullapanthula¹,Adela Ramu²^ORCID,Murty Upadhyayula Suryanarayana³,Borkar Roshan M.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India

2. Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India

3. National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India

Funder

National Mission on Himalayan Studies

Ministry of Environment, Forest and Climate Change, Government of India

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2021.1928687

Reference237 articles.

1. About MEDLINE® and PubMed®: The Resources Guide. 2021. United States: National Library of Medicine; [accessed 2021 Mar 30]. https://www.nlm.nih.gov/bsd/pmresources.html.

2. In silico methods for predicting drug–drug interactions with cytochrome P-450s, transporters and beyond

3. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner

4. Carvedilol increases ciclosporin bioavailability by inhibiting P-glycoprotein-mediated transport

5. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users;British Journal of Clinical Pharmacology;2024-08-19

2. New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans;Clinical Pharmacology & Therapeutics;2024-08-15

3. Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges;Clinical Pharmacokinetics;2024-06-18

4. Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7–16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson’s Disease;Molecules;2024-05-08

5. A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions;Clinical Pharmacology & Therapeutics;2023-08-18